Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV
Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…
CertaraOctober 5, 2026
Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma
Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…
CertaraOctober 5, 2026
From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs
New CPT review by Certara's Karen Rowland Yeo & Piet van der Graaf shows how…
Danielle PillsburySeptember 23, 2026
Model-Informed Strategies for ADC Development
Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…
Danielle PillsburySeptember 22, 2026
Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers
A semi-mechanistic population PK model characterizes sorfequiline and its active M3 metabolite to support DDI…
CertaraSeptember 18, 2026
Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy
Pharmacometric modeling of givinostat in pediatric DMD supported a simplified 4-band weight-based dosing regimen without…
CertaraSeptember 14, 2026
